Longitudinal analysis of antibody responses to HIV-1:mapping function to genotype

HIV-1 抗体反应的纵向分析:将功能映射到基因型

基本信息

项目摘要

DESCRIPTION (provided by applicant): To date no vaccination strategy against Human Immunodeficiency Virus (HIV) has been widely successful. HIV has developed mechanisms to escape the humoral response through a high mutation rate. In a subset of HIV-1 infected individuals, broadly neutralizing antibodies (bNAbs) have developed. These potent antibodies target preserved epitopes on the viral envelope across multiple clades. A viable vaccination strategy likely necessitates determining the mechanisms by which bNAbs evolve upon exposure to immunogens. The following two questions are addressed in this proposal: 1) How does the antibody repertoire evolve in HIV-1 infected individuals over time? 2) How does the functional antibody response to HIV-1 correlate to evolutionary stage? These questions will be addressed in Aim 1) which proposes to deep sequence longitudinal B-cell repertoires from HIV-1 infected individuals, using the sequences to assemble a phylogenetic tree depicting the divergent evolution of the antibody repertoires in individuals with broadly versus poorly neutralizing activity. Aim 2) proposes to perform a functional antibody phenotype screen of single B-cells from the same repertoires deep sequenced in Aim 1. The functional phenotype information will be linked to the phylogenetic map to identify bNAbs and their clonal ancestors. This will provide insight into the mechanisms of how bNAbs naturally evolve. Our results will contribute to the development of HIV-1 vaccination strategies by providing a blueprint for the elicitation of bNAbs.
描述(由申请人提供):迄今为止,没有针对人类免疫缺陷病毒(HIV)的疫苗接种策略获得广泛成功。HIV已经发展出通过高突变率来逃避体液反应的机制。在一部分HIV-1感染个体中,产生了广泛中和抗体(bNAbs)。这些强效抗体针对多个进化支的病毒包膜上保存的抗原表位。一个可行的疫苗接种策略可能需要确定bnab在暴露于免疫原后进化的机制。本提案解决了以下两个问题:1)HIV-1感染个体的抗体库如何随时间演变?2) HIV-1的功能性抗体应答与进化阶段有何关联?这些问题将在目标1中得到解决,该目标提出对HIV-1感染个体的纵向b细胞谱进行深度测序,使用这些序列组装一个系统发育树,描绘具有广泛中和活性和较差中和活性的个体的抗体谱的不同进化。Aim 2)建议对来自Aim 1中深度测序的相同基因库的单个b细胞进行功能性抗体表型筛选。功能表型信息将与系统发育图谱相关联,以鉴定bNAbs及其克隆祖先。这将有助于深入了解bnab自然进化的机制。我们的研究结果将有助于HIV-1疫苗接种策略的发展,为bNAbs的激发提供蓝图。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Konstantinos Tsioris其他文献

Konstantinos Tsioris的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Konstantinos Tsioris', 18)}}的其他基金

Longitudinal analysis of antibody responses to HIV-1:mapping function to genotype
HIV-1 抗体反应的纵向分析:将功能映射到基因型
  • 批准号:
    8995571
  • 财政年份:
    2014
  • 资助金额:
    $ 5.14万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 5.14万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 5.14万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 5.14万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 5.14万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 5.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 5.14万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 5.14万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 5.14万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 5.14万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 5.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了